Uncovering host response in adults with severe community-acquired pneumonia: a proteomics and metabolomics perspective study

doi:10.5847/wjem.j.1920-8642.2025.063

Abstract

Abstract:

BACKGROUND: Community-acquired pneumonia (CAP) represents a significant public health concern due to its widespread prevalence and substantial healthcare costs. This study was to utilize an integrated proteomic and metabolomic approach to explore the mechanisms involved in severe CAP.

METHODS: We integrated proteomics and metabolomics data to identify potential biomarkers for early diagnosis of severe CAP. Plasma samples were collected from 46 CAP patients (including 27 with severe CAP and 19 with non-severe CAP) and 19 healthy controls upon admission. A comprehensive analysis of the combined proteomics and metabolomics data was then performed to elucidate the key pathological features associated with CAP severity.

RESULTS: The proteomic and metabolic signature was markedly different between CAPs and healthy controls. Pathway analysis of changes revealed complement and coagulation cascades, ribosome, tumor necrosis factor (TNF) signaling pathway and lipid metabolic process as contributors to CAP. Furthermore, alterations in lipid metabolism, including sphingolipids and phosphatidylcholines (PCs), and dysregulation of cadherin binding were observed, potentially contributing to the development of severe CAP. Specifically, within the severe CAP group, sphingosine-1-phosphate (S1P) and apolipoproteins (APOC1 and APOA2) levels were downregulated, while S100P level was significantly upregulated.

CONCLUSION: The combined proteomic and metabolomic analysis may elucidate the complexity of CAP severity and inform the development of improved diagnostic tools.

Key words: Community-acquired pneumonia, Proteomics, Metabolomics, Machine learning

Zhongshu Kuang, Runrong Li, Su Lu, Yusong Wang, Yue Luo, Yongqi Shen, Li Yuan, Yilin Yang, Zhenju Song, Ning Jiang, Chaoyang Tong. Uncovering host response in adults with severe community-acquired pneumonia: a proteomics and metabolomics perspective study[J]. World Journal of Emergency Medicine, 2025, 16(3): 248-255.

Figures/Tables 3

Figure 1.

Figure 2.

Figure 3.

References 29

1	Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI. Community-acquired pneumonia. Lancet. 2021; 398(10303): 906-19. doi: 10.1016/S0140-6736(21)00630-9 pmid: 34481570
2	Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015; 373(5): 415-27.
3	Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017; 65(11): 1806-12. doi: 10.1093/cid/cix647 pmid: 29020164
4	Sun Y, Sun B, Ren Z, Xue M, Zhu C, Liu Q. Heparin-binding protein as a predictor of mortality in patients with diabetes mellitus and community-acquired pneumonia in intensive care unit : a propensity score matched study. World J Emerg Med. 2024; 15(4):263-72. doi: 10.5847/wjem.j.1920-8642.2024.033 pmid: 39050224
5	Laguna-Goya R, Utrero-Rico A, Talayero P, Lasa-Lazaro M, Ramirez-Fernandez A, Naranjo L, et al. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020; 146(4): 799-807.e9. doi: 10.1016/j.jaci.2020.07.009 pmid: 32710975
6	Costanzo M, Caterino M, Fedele R, Cevenini A, Pontillo M, Barra L, et al. COVIDomics: the proteomic and metabolomic signatures of COVID-19. Int J Mol Sci. 2022; 23(5): 2414.
7	Cao B, Huang Y, She DY, Cheng QJ, Fan H, Tian XL, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Respir J. 2018; 12(4): 1320-60. doi: 10.1111/crj.12674 pmid: 28756639
8	Yan C, Xue GH, Zhao HQ, Feng YL, Cui JH, Yuan J. Current status of Mycoplasma pneumoniae infection in China. World J Pediatr. 2024; 20(1):1-4. doi: 10.1007/s12519-023-00783-x pmid: 38185707
9	Pang ZQ, Lu Y, Zhou GY, Hui F, Xu L, Viau C, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024; 52(W1): W398-W406.
10	Lopez-Ibañez J, Pazos F, Chagoyen M. MBROLE3: improved functional enrichment of chemical compounds for metabolomics data analysis. Nucleic Acids Res. 2023; 51(W1): W305-W309. doi: 10.1093/nar/gkad405 pmid: 37178003
11	Kumar L, Futschik ME. Mfuzz: a software package for soft clustering of microarray data. Bioinformation. 2007; 2(1): 5-7. doi: 10.6026/97320630002005 pmid: 18084642
12	Fung HB, Monteagudo-Chu MO. Community-acquired pneumonia in the elderly. Am J Geriatr Pharmacother. 2010; 8(1): 47-62. doi: 10.1016/j.amjopharm.2010.01.003 pmid: 20226392
13	Wang Y, Huang XL, Li F, Jia XB, Jia N, Fu J, et al. Serum-integrated omics reveal the host response landscape for severe pediatric community-acquired pneumonia. Crit Care. 2023; 27(1): 79.
14	Lekkou A, Mouzaki A, Siagris D, Ravani I, Gogos CA. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J Crit Care. 2014; 29(5): 723-7. doi: 10.1016/j.jcrc.2014.04.018 pmid: 24891152
15	Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018; 19(3): 175-91.
16	Piotti A, Novelli D, Meessen JMTA, Ferlicca D, Coppolecchia S, Marino A, et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. Crit Care. 2021; 25(1): 113.
17	Lin MN, Xu FX, Sun J, Song JF, Shen Y, Lu S, et al. Integrative multiomics analysis unravels the host response landscape and reveals a serum protein panel for early prognosis prediction for ARDS. Crit Care. 2024; 28(1): 213.
18	Wang KM, Khoramjoo M, Srinivasan K, Gordon PMK, Mandal R, Jackson D, et al. Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID. Cell Rep Med. 2023; 4(11): 101254.
19	Neugebauer S, Giamarellos-Bourboulis EJ, Pelekanou A, Marioli A, Baziaka F, Tsangaris I, et al. Metabolite profiles in sepsis: developing prognostic tools based on the type of infection. Crit Care Med. 2016; 44(9): 1649-62. doi: 10.1097/CCM.0000000000001740 pmid: 27097292
20	Arshad H, Alfonso JCL, Franke R, Michaelis K, Araujo L, Habib A, et al. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia. J Transl Med. 2019; 17(1): 365. doi: 10.1186/s12967-019-2112-z pmid: 31711507
21	Prica F, Radon T, Cheng YZ, Crnogorac-Jurcevic T. The life and works of S100P - from conception to cancer. Am J Cancer Res. 2016; 6(2): 562-76. pmid: 27186425
22	Lu JY, Li Q, Wu ZM, Zhong ZM, Ji P, Li HY, et al. Two gene set variation indexes as potential diagnostic tool for sepsis. Am J Transl Res. 2020; 12(6): 2749-59. pmid: 32655806
23	Zhao YJ, Yuan JL, Xiao D, Zhang LW, Li C, Hu JF, et al. HSP90AB 1 is a host factor that promotes porcine deltacoronavirus replication. J Biol Chem. 2024; 300(1): 105536.
24	Zhang SJ, Huang WZ, Ren LL, Ju XH, Gong ML, Rao J, et al. Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2. Cell Res. 2022; 32(1): 9-23.
25	Song DL, Zhao YJ, Sun Y, Liang YX, Chen R, Wen YP, et al. HSP90AB 1 is a host factor required for transmissible gastroenteritis virus infection. Int J Mol Sci. 2023; 24(21): 15971.
26	Lagresle-Peyrou C, Luce S, Ouchani F, Soheili TS, Sadek H, Chouteau M, et al. X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene. J Allergy Clin Immunol. 2016; 138(6): 1681-9.e8. doi: S0091-6749(16)30423-7 pmid: 27405666
27	Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 2011; 471: 591-6.
28	Amin J, Boche D, Rakic S. What do we know about the inflammasome in humans? Brain Pathol. 2017; 27(2): 192-204.
29	Armitage EG, Godzien J, Alonso-Herranz V, López-Gonzálvez Á, Barbas C. Missing value imputation strategies for metabolomics data. Electrophoresis. 2015; 36(24): 3050-60. doi: 10.1002/elps.201500352 pmid: 26376450

[1]	Weiming Wu, Min Li, Huilin Jiang, Min Sun, Yongcheng Zhu, Gongxu Zhu, Yanling Li, Yunmei Li, Junrong Mo, Xiaohui Chen, Haifeng Mao. Development of an emergency department length-of-stay prediction model based on machine learning [J]. World Journal of Emergency Medicine, 2025, 16(3): 220-224.
[2]	Qingyuan Liu, Yixin Zhang, Jian Sun, Kaipeng Wang, Yueguo Wang, Yulan Wang, Cailing Ren, Yan Wang, Jiashan Zhu, Shusheng Zhou, Mengping Zhang, Yinglei Lai, Kui Jin. Early identification of high-risk patients admitted to emergency departments using vital signs and machine learning [J]. World Journal of Emergency Medicine, 2025, 16(2): 113-120.
[3]	Jingyuan Xie, Jiandong Gao, Mutian Yang, Ting Zhang, Yecheng Liu, Yutong Chen, Zetong Liu, Qimin Mei, Zhimao Li, Huadong Zhu, Ji Wu. Prediction of sepsis within 24 hours at the triage stage in emergency departments using machine learning [J]. World Journal of Emergency Medicine, 2024, 15(5): 379-385.
[4]	Yuhan Sun, Baoqing Sun, Zhigang Ren, Mingshan Xue, Changju Zhu, Qi Liu. Heparin-binding protein as a predictor of mortality in patients with diabetes mellitus and community-acquired pneumonia in intensive care unit : a propensity score matched study [J]. World Journal of Emergency Medicine, 2024, 15(4): 263-272.
[5]	Rebekah Shaw, Erica Popovsky, Alyssa Abo, Marni Jacobs, Nicole Herrera, James Chamberlain, Andrea Hahn. Improving antibiotic prescribing in the emergency department for uncomplicated community-acquired pneumonia [J]. World Journal of Emergency Medicine, 2020, 11(4): 199-205.
[6]	Hai-jiang Zhou, Tian-fei Lan, Shu-bin Guo. Outcome prediction value of National Early Warning Score in septic patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study [J]. World Journal of Emergency Medicine, 2020, 11(4): 206-215.
[7]	Zhong-shu Kuang, Yi-lin Yang, Wei Wei, Jian-li Wang, Xiang-yu Long, Ke-yong Li, Chao-yang Tong, Zhan Sun, Zhen-ju Song. Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: A retrospective observational study [J]. World Journal of Emergency Medicine, 2020, 11(3): 145-151.
[8]	Li-ping Chen, Jun-hui Chen, Ying Chen, Chao Wu, Xiao-hong Yang. Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: A meta-analysis of randomized controlled trials [J]. World Journal of Emergency Medicine, 2015, 6(3): 172-178.
[9]	Jing Li, Huan Ye, Li Zhao. B-type natriuretic peptide in predicting the severity of community-acquired pneumonia [J]. World Journal of Emergency Medicine, 2015, 6(2): 131-136.
[10]	Samuel George Campbell, R. Andrew McIvor, Vincent Joanis, David Graydon Urquhart. Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures? [J]. World Journal of Emergency Medicine, 2011, 2(4): 272-278.